Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sen. Ron Johnson (R-Wis.) speaking during a press conference on June 10. Photo: Anna Moneymaker/Getty Images

YouTube has temporarily suspended Sen. Ron Johnson (R-Wis.) for violating its policy on medical misinformation after he posted a video promoting hydroxychloroquine and other drugs for treating COVID-19.

Why it matters: Some Republicans, most prominently former President Trump, have promoted the antimalarial drug hydroxychloroquine as a method to fight the coronavirus, even though clinical trials have shown it does not prevent people from getting COVID-19 and does not work as a treatment for the illness.

Context: Johnson uploaded a video of a virtual event hosted by the Milwaukee Press Club in which he supported hydroxychloroquine and ivermectin — an anti-parasite drug — as treatments that could help end the pandemic.

  • In the June 3 virtual appearance, Johnson criticized the Trump and Biden administrations for “not only ignoring but working against robust research [on] the use of cheap, generic drugs to be repurposed for early treatment of Covid,” the Milwaukee Journal Sentinel reports.

"YouTube doesn't allow content that spreads medical misinformation that contradicts local health authorities’ or the World Health Organization’s (WHO) medical information about COVID-19," the video-sharing platform's COVID-19 medical misinformation policy reads.

What they're saying: YouTube removed the video Friday "in accordance with our COVID-19 medical misinformation policies, which don’t allow content that encourages people to use Hydroxychloroquine or Ivermectin to treat or prevent the virus,” a YouTube spokesperson told Fox News.

  • Johnson, who is blocked from uploading videos for one week, told Fox News that "YouTube's ongoing COVID censorship proves they have accumulated too much unaccountable power."
  • "Big Tech and mainstream media believe they are smarter than medical doctors who have devoted their lives to science and use their skills to save lives," he claimed.

The big picture: Though the treatments Johnson supported don't prevent or treat COVID-19, pharmaceutical companies have developed other drugs to treat the illness and are attempting to develop medications to prevent the virus from infecting people.

  • The Food and Drug Administration approved a lower dose of Regeneron’s coronavirus treatment for injection last week, which will make it easier for doctors to administer the treatment to patients.
  • Pfizer is developing an oral antiviral drug to stop the virus that causes COVID-19 from replicating, and it could be ready next year.

Go deeper

Sep 18, 2021 - Health

Mississippi reports rise in COVID-19 deaths among pregnant women

Dr. Thomas Dobbs speaks during a House Homeland Security Subcommittee hearing in Washington, D.C., on March 10, 2020. Photo: Andrew Harrer/Bloomberg via Getty Images

At least eight pregnant women in Mississippi, who weren't fully vaccinated, have died of COVID-19 since late July, CNN reports.

Why it matters: The eight pregnant women who have died from the virus more than doubles the state's pandemic total in just two months.

Sep 17, 2021 - Health

CDC: Moderna vaccine most effective against hospitalization in U.S.

Illustration: Shoshana Gordon/Axios

Overall healthy adults with the Moderna COVID vaccine had 93% vaccine effectiveness against hospitalization over five months compared to those with 88% protection with Pfizer and 71% from the Johnson & Johnson vaccine, a new report out Friday from the CDC shows.

Why it matters: The report comes as the Food and Drug Administrations meets Friday to consider whether to endorse a contentious plan for booster shots among the fully vaccinated.

Scoop: Trump's new social network quietly courting influencers

Illustration: Lazaro Gamio/Axios

Former President Trump’s elusive new social media network Truth Social — which plans to go public — is reaching out to internet influencers asking them to “reserve their spots” for when it launches in February or March.

Why it matters: The outreach doesn’t mention Trump’s name or affiliation. Some influencers suggest that could be a ploy to enlist their support without realizing the affiliation.